Director at $EXEL sells 99574 shares in insider sale

A recent insider sale at $EXEL saw director Jack L Wyszomierski dispose of 99,574 shares for approximately $4,382,251 on February 18, 2026. This sale accounted for around 26.2% of their holdings in this class of stock, leaving them with 279,942 shares of $EXEL stock. This transaction was disclosed in a recent SEC filing.

$EXEL has witnessed insider trading activity on the open market 21 times within the past 6 months, with 1 purchase and 20 sales recorded. Some notable recent trades by company insiders include EVP, Commercial Patrick J. Haley selling 140,044 shares, EVP and CFO Christopher J. Senner offloading 64,895 shares, and EVP, Research and Development Dana Aftab selling 48,383 shares. Additionally, SVP and General Counsel Brenda Hefti and Sue Gail Eckhardt have also divested a significant number of shares in recent sales transactions.

In terms of hedge fund activity, 332 institutional investors have increased their positions in $EXEL stock, while 363 have decreased their holdings in the most recent quarter. Notable movements by hedge funds include AQR Capital Management LLC adding 4,477,029 shares, valued at $196,228,181, to their portfolio in Q4 2025, while Farallon Capital Management LLC removed 3,792,000 shares, worth $166,203,360. UBS AM, D. E. Shaw & Co., Inc., and Renaissance Technologies LLC were among the other major players making significant adjustments to their $EXEL holdings in the same period.

On the revenue front, $EXEL reported revenues of $598.7 million in Q4 2025, marking a 5.63% increase year-over-year. This positive revenue growth reflects the company’s performance and business outlook for the future.

Analysts covering $EXEL have issued buy ratings for the stock, with 4 firms offering positive recommendations. HC Wainwright & Co., TD Cowen, Leerink Partners, and Goldman Sachs are among the firms that have recently issued buy ratings for $EXEL. These ratings indicate a favorable outlook for the company’s stock performance.

Price targets by multiple analysts for $EXEL have been set in the last 6 months, with a median target of $46.0. Analysts like Robert Burns from HC Wainwright & Co., Eva Fortea Verdejo from Wells Fargo, and Leonid Timashev from RBC Capital have set higher price targets, indicating optimism for future stock performance.

Please note that this article is not financial advice, and readers are advised to refer to Quiver Quantitative’s disclaimers for more information on the subject.